Literature DB >> 30074631

Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab.

Stefanie Aeppli1, Christoph Driessen1, Lukas Graf2, Felicitas Hitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30074631     DOI： 10.1002/hon.2533

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  5 in total

1.  The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma.

Authors:  Zhenchang Sun; Wenjuan Wan; Xudong Zhang; Lei Zhang; Xin Li; Ling Li; Xinhua Wang; Feifei Nan; Hui Yu; Yu Chang; Jiaqin Yan; Zhaoming Li; Fangfang Cui; Jurui Ge; Yaqin Duo XiaXu; Xia Xu; Xiaorui Fu; Mingzhi Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-20       Impact factor: 4.322

Review 2.  Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders.

Authors:  Susan Swee-Shan Hue; Siok-Bian Ng; Shi Wang; Soo-Yong Tan
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

Review 3.  Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions.

Authors:  John C Reneau; Polina Shindiapina; Zachary Braunstein; Youssef Youssef; Miguel Ruiz; Saira Farid; Walter Hanel; Jonathan E Brammer
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

Review 4.  Extranodal NK/T cell lymphoma.

Authors:  Seong Hyun Jeong
Journal:  Blood Res       Date:  2020-07-31

Review 5.  Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment.

Authors:  Jaap A van Doesum; Anne G H Niezink; Gerwin A Huls; Max Beijert; Arjan Diepstra; Tom van Meerten
Journal:  Hemasphere       Date:  2021-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.